The role of PLA2R antibody monitoring: what we know and what we do not know

P Ronco, E Plaisier, H Debiec - Nephrology Dialysis …, 2023 - academic.oup.com
For a long time, kidney biopsy was the only diagnostic means for membranous nephropathy
(MN) and proteinuria and serum creatinine were the only markers of disease activity. The …

[HTML][HTML] Antibody-guided therapy in phospholipase A2 receptor-associated membranous nephropathy

CH Vink, AE van de Logt, RG van der Molen… - Kidney International …, 2023 - Elsevier
Introduction A 6-month course of cyclophosphamide (CP) and steroids is effective in primary
membranous nephropathy (MN), but unappealing because of long-term side effects. We …

[HTML][HTML] A comparison of chemiluminescent immunoassay and enzyme-linked immunosorbent assay for detecting phospholipase A2 receptor antibody in primary …

X Ma, R Wang, L Wei, P Liu, L Jing, J Wang… - Practical Laboratory …, 2024 - Elsevier
Objective The accurate detection of phospholipase A2 receptor (PLA2R) autoantibody is
crucial in the diagnosis and monitoring of primary membranous nephropathy (pMN). While …

Мембранозный гломерулонефрит в практике терапевта

ИТ Муркамилов, ИС Сабиров, ВВ Фомин… - Клиническая …, 2021 - elibrary.ru
Мембранозный гломерулонефрит (мГЛН) характеризуется диффузным утолщением и
изменением структуры базальной мембраны клубочков вследствие субэпителиальной …

Membranose glomerulonephritis in the practice of a therapist

IT Murkamilov, IS Sabirov, VV Fomin… - Clinical …, 2021 - gynecology.orscience.ru
Membranous glomerulonephritis (MGN) is characterized by diffuse thickening and changes
in the structure of the basement membrane of the glomeruli due to subepithelial and …